8 March 2023
At the meeting of 7 February 2023 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| warts | 7/2023 | 8/2023 |
| vascular neurocognitive disorder | 9/2023 | 10/2023 |
| cervical spondylosis | 11/2023 | 12/2023 |
| mitral valve prolapse | 15/2023 | 16/2023 |
| chronic obstructive pulmonary disease | 17/2023 | 18/2023 |
| periodic limb movement disorder | 19/2023 | 20/2023 |
Note:
- The investigation concerning “vascular dementia” has resulted in the determination of a Statements of Principles concerning vascular neurocognitive disorder.
Determined New Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| thoracolumbar spondylosis | 13/2023 | 14/2023 |
Note:
- The investigations concerning "thoracic spondylosis” and “lumbar spondylosis” have resulted in the determination of a Statements of Principles concerning thoracolumbar spondylosis.
The above SOPs take effect from 27 March 2023.
Decided to Undertake Consultation regarding:
| Condition | Reasons for Decision | Date for Final Decision |
|---|---|---|
| intervertebral disc prolapse | Intention to remove one or more factors | June 2023 |
| malignant neoplasm of the stomach | Intention to remove one or more factors | June 2023 |
| Hodgkin lymphoma | Intention to remove one or more factors | June 2023 |
| peripheral neuropathy | Intention to remove one or more factors | June 2023 |
Completed Investigations
The above determinations conclude the previously advertised investigations into: